combining semaglutide and tirzepatide mixing with Comparative safety side effects of semaglutide and tirzepatide: Implications for clinical decision-making in Semaglutide vs. Tirzepatide for Weight

Key Findings 93.4% of patients would get bariatric surgery again 51.4% of patients would consider using GLP-1 drugs again 57.1% of GLP-1 patients reported losing at least 20 pounds 98.1% of bariatric surgery patients reported losing at least 20 pounds Median weight loss for bariatric surgery patients was 100 pounds, as opposed to 20 for GLP-1s Average weight loss for bariatric surgery was reported to be 101.2, as opposed to 24.9 for GLP-1 users 93.4% of Patients Would Get Bariatric Surgery Again Out of all patients surveyed, 93.4% said they would get bariatric surgery again

Dihexa: two retractions in 2025

[DOI] [PMC free article] [PubMed] [Google Scholar] 23.Lagouge M, et al

According to the company's website, ProHealth BPC-157 is described as containing 500mcg of what the company characterizes as pharmaceutical-grade BPC-157 in arginate salt form, with pricing listed on the product page and subject to change